Combination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model

Hong,Yunchuan; Sun,Li; Sun,Ruiqiang; Chen,Hongguang; Yu,Yonghao; Xie,Keliang

doi:10.3892/etm.2016.3231

Combination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model

Authors:
- Yunchuan Hong
- Li Sun
- Ruiqiang Sun
- Hongguang Chen
- Yonghao Yu
- Keliang Xie
View Affiliations

Affiliations: Department of Respiratory Medicine, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China, Department of Anesthesiology, General Hospital of Beijing Military Command, Beijing 100700, P.R. China, Department of Anesthesiology, Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, P.R. China, Department of Anesthesiology, Tianjin Institute of Anesthesiology, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China
Published online on: April 6, 2016 https://doi.org/10.3892/etm.2016.3231
Pages: 2590-2596

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple organ dysfunction syndrome (MODS) is a leading cause of mortality in critically ill patients. Hyperoxia treatment may be beneficial to critically ill patients. However, the clinical use of hyperoxia is hindered as it may exacerbate organ injury by increasing reactive oxygen species (ROS). Hydrogen gas (H2) exerts a therapeutic antioxidative effect by selectively reducing ROS. Combination therapy of H2 and hyperoxia has previously been shown to significantly improve survival rate and organ damage extent in mice with polymicrobial sepsis. The aim of the present study was to investigate whether combination therapy with H2 and hyperoxia could improve survival rate and organ damage in a zymosan (ZY)‑induced generalized inflammation model. The results showed that the inhalation of H2 (2%) or hyperoxia (98%) alone improved the 14‑day survival rate of ZY-challenged mice from 20 to 70 or 60%, respectively. However, combination therapy with H2 and hyperoxia could increase the 14‑day survival rate of ZY‑challenged mice to 100%. Furthermore, ZY‑challenged mice showed significant multiple organ damage characterized by increased serum levels of aspartate transaminase, alanine transaminase, blood urea nitrogen and creatinine, as well as lung, liver and kidney histopathological scores at 24 h after ZY injection. These symptoms where attenuated by H2 or hyperoxia alone; however, combination therapy with H2 and hyperoxia had a more marked beneficial effect against lung, liver and kidney damage in ZY-challenged mice. In addition, the beneficial effects of this combination therapy on ZY‑induced organ damage were associated with decreased serum levels of the oxidative product 8‑iso‑prostaglandin F2α, increased activity of superoxide dismutase and reduced levels of the proinflammatory cytokines high‑mobility group box 1 and tumor necrosis factor‑α. In conclusion, combination therapy with H2 and hyperoxia provides enhanced therapeutic efficacy against multiple organ damage in a ZY‑induced generalized inflammation model, suggesting the potential applicability of H2 and hyperoxia in the therapy of conditions associated with inflammation-related MODS.

View Figures

View References

1	Martin GS, Mannino DM, Eaton S and Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 348:1546–1554. 2003. View Article : Google Scholar : PubMed/NCBI
2	Shayevitz JR, Miller C, Johnson KJ and Rodriguez JL: Multiple organ dysfunction syndrome: End organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock. 4:389–396. 1995.PubMed/NCBI
3	Hotchkiss RS and Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 348:138–150. 2003. View Article : Google Scholar : PubMed/NCBI
4	Asfar P, Calzia E, Huber-Lang M, Ignatius A and Radermacher P: Hyperoxia during septic shock-Dr. Jekyll or Mr. Hyde? Shock. 37:122–123. 2012. View Article : Google Scholar : PubMed/NCBI
5	Waisman D, Brod V, Rahat MA, Amit-Cohen BC, Lahat N, Rimar D, Menn-Josephy H, David M, Lavon O, Cavari Y and Bitterman H: Dose-related effects of hyperoxia on the lung inflammatory response in septic rats. Shock. 37:35–102. 2012. View Article : Google Scholar
6	Hauser B, Barth E, Bassi G, Simon F, Gröger M, Oter S, Speit G, Ploner F, Möller P, Wachter U, et al: Hemodynamic, metabolic and organ function effects of pure oxygen ventilation during established fecal peritonitis-induced septic shock. Crit Care Med. 37:2465–2469. 2009. View Article : Google Scholar : PubMed/NCBI
7	Barth E, Bassi G, Maybauer DM, Simon F, Gröger M, Oter S, Speit G, Nguyen CD, Hasel C, Möller P, et al: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med. 36:495–503. 2008. View Article : Google Scholar : PubMed/NCBI
8	Hou L, Xie K, Li N, Qin M, Lu Y, Ma S, Ji G and Xiong L: 100% oxygen inhalation protects against zymosan-induced sterile sepsis in mice: The roles of inflammatory cytokines and antioxidant enzymes. Shock. 32:451–461. 2009. View Article : Google Scholar : PubMed/NCBI
9	Folz RJ, Abushamaa AM and Suliman HB: Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest. 103:1055–1066. 1999. View Article : Google Scholar : PubMed/NCBI
10	Altemeier WA and Sinclair SE: Hyperoxia in the intensive care unit: Why more is not always better. Curr Opin Crit Care. 13:73–78. 2007. View Article : Google Scholar : PubMed/NCBI
11	Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S and Ohta S: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 13:688–694. 2007. View Article : Google Scholar : PubMed/NCBI
12	Ohta S: Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nippon Ronen Igakkai Zasshi. 45:355–362. 2008.(In Japanese). PubMed/NCBI
13	Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I and Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 361:670–674. 2007. View Article : Google Scholar : PubMed/NCBI
14	Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H and Li R: Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 441:167–172. 2008. View Article : Google Scholar : PubMed/NCBI
15	Huang CS, Kawamura T, Toyoda Y and Nakao A: Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 44:971–982. 2010. View Article : Google Scholar : PubMed/NCBI
16	Xie K, Fu W, Xing W, Li A, Chen H, Han H, Yu Y and Wang G: Combination therapy with molecular hydrogen and hyperoxia in a murine model of polymicrobial sepsis. Shock. 38:656–663. 2012.PubMed/NCBI
17	Cuzzocrea S, Costantino G, Mazzon E and Caputi AP: Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med. 27:1524–1532. 1999. View Article : Google Scholar : PubMed/NCBI
18	Volman TJ, Hendriks T and Goris RJ: Zymosan-induced generalized inflammation: Experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock. 23:291–297. 2005. View Article : Google Scholar : PubMed/NCBI
19	Humphreys K, Weingardt KR and Harris AH: Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res. 31:988–995. 2007. View Article : Google Scholar : PubMed/NCBI
20	Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L and Wang G: Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock. 34:90–97. 2010. View Article : Google Scholar : PubMed/NCBI
21	Xie K, Yu Y, Zhang Z, Liu W, Pei Y, Xiong L, Hou L and Wang G: Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock. 34:495–501. 2010. View Article : Google Scholar : PubMed/NCBI
22	Hou L, Xie K, Qin M, Peng D, Ma S, Shang L, Li N, Li S, Ji G, Lu Y and Xiong L: Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice. Shock. 33:646–654. 2010. View Article : Google Scholar : PubMed/NCBI
23	Dworski R, Roberts LJ II, Murray JJ, Morrow JD, Hartert TV and Sheller JR: Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy. 31:387–390. 2001. View Article : Google Scholar : PubMed/NCBI
24	Martin DS and Grocott MP: Oxygen therapy in critical illness: Precise control of arterial oxygenation and permissive hypoxemia. Crit Care Med. 41:423–432. 2013. View Article : Google Scholar : PubMed/NCBI
25	Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E and Tomlanovich M: Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 345:1368–1377. 2001. View Article : Google Scholar : PubMed/NCBI
26	Meier J, Kemming GI, Kisch-Wedel H, Blum J, Pape A and Habler OP: Hyperoxic ventilation reduces six-hour mortality after partial fluid resuscitation from hemorrhagic shock. Shock. 22:240–247. 2004. View Article : Google Scholar : PubMed/NCBI
27	Sukhotnik I, Krausz MM, Brod V, Balan M, Turkieh A, Siplovich L and Bitterman H: Divergent effects of oxygen therapy in four models of uncontrolled hemorrhagic shock. Shock. 18:277–284. 2002. View Article : Google Scholar : PubMed/NCBI
28	Kayar SR and Fahlman A: Decompression sickness risk reduced by native intestinal flora in pigs after H2 dives. Undersea Hyperb Med. 28:89–97. 2001.PubMed/NCBI
29	Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
30	Hou LC, Qin MZ, Zheng LN, Lu Y, Wang Q, Peng DR, Yu XP, Xin YC, Ji GL and Xiong LZ: Severity of sepsis correlated with the elevation of serum high-mobility group box 1 in rats. Chin Med J (Engl). 122:449–454. 2009.PubMed/NCBI